The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE

L. J. Tsai, S. H. Hsiao, L. M. Tsai, C. Y. Lin, J. J. Tsai, D. M. Liou, J. L. Lan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Genetic studies in several human autoimmune diseases suggest that the pericentromeric region of chromosome 16 might harbor an autoimmune modifier gene. We hypothesized that the sodium-dependent glucose cotransporter gene SLC5A11 is such a gene, and so might interact with immune-related genes. Herein, this hypothesis was tested in a genetic evaluation of the multiple gene effect in systemic lupus erythematosus (SLE). We used the case-control candidate gene association approach. Eight immune-related genes involved in inflammation and autoantibody generation and clear-up [interleukin 1 receptor antagonist (IL1RN), interleukin 1-beta (IL1-β), tumor necrosis factor-alpha (TNF-α), lymphotoxin-alpha (LTA), tumor necrosis factor ligand superfamily, member 6 (TNFSF6), programmed cell death 1 (PDCD1), C2, and complement component 4 (C4)] were selected for study. Frequency of each candidate's genotype and allele between case and control were compared. Results were stratified by reanalyzing genotype data with relevant symptoms. Finally, improved computational data mining was used to analyze the phenotypes in a large data set. In the frequency analysis, only IL1-β was significantly associated with SLE. Stratification analysis showed a significant association with SLE symptoms between SLC5A11 and the other immune-related genes, with the exceptions of TNFSF6 and C4. SLC5A11 was significantly associated with low C4 (as was TNF-α), anti-Smith antibody (anti-Sm) (as was C2), serositis, and alopecia. Finally, SLC5A11 interacted with PDCD1, TNF-α, LTA, and C4. After our study, we concluded that SLC5A11 is involved with some immune effects and interacts with immune-related gene(s), consistent with its function as an autoimmune modifier gene. Furthermore, SLC5A11 might induce apoptosis through the TNF-α, PDCD1 pathway. The present genotype-phenotype mapping approach should be applicable to genetic study of other complex diseases.

Original languageEnglish
Pages (from-to)114-126
Number of pages13
JournalTissue Antigens
Volume71
Issue number2
DOIs
Publication statusPublished - Feb 1 2008
Externally publishedYes

Fingerprint

Sodium-Glucose Transport Proteins
Modifier Genes
Systemic Lupus Erythematosus
Genes
Sodium
Glucose
Lymphotoxin-alpha
Cell death
Tumor Necrosis Factor-alpha
Fas Ligand Protein
Cell Death
Genotype
Interleukin-1beta
Serositis
Complement C4
Phenotype
Chromosomes, Human, Pair 16
Data Mining
Interleukin-1 Receptors
Alopecia

Keywords

  • Autoimmune modifier gene
  • Candidate gene association approach
  • Data mining
  • Sodium-dependent glucose cotransporter
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Biochemistry
  • Genetics

Cite this

The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE. / Tsai, L. J.; Hsiao, S. H.; Tsai, L. M.; Lin, C. Y.; Tsai, J. J.; Liou, D. M.; Lan, J. L.

In: Tissue Antigens, Vol. 71, No. 2, 01.02.2008, p. 114-126.

Research output: Contribution to journalArticle

Tsai, L. J. ; Hsiao, S. H. ; Tsai, L. M. ; Lin, C. Y. ; Tsai, J. J. ; Liou, D. M. ; Lan, J. L. / The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE. In: Tissue Antigens. 2008 ; Vol. 71, No. 2. pp. 114-126.
@article{4b66dc27888d4f8984534d4a7c74de66,
title = "The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE",
abstract = "Genetic studies in several human autoimmune diseases suggest that the pericentromeric region of chromosome 16 might harbor an autoimmune modifier gene. We hypothesized that the sodium-dependent glucose cotransporter gene SLC5A11 is such a gene, and so might interact with immune-related genes. Herein, this hypothesis was tested in a genetic evaluation of the multiple gene effect in systemic lupus erythematosus (SLE). We used the case-control candidate gene association approach. Eight immune-related genes involved in inflammation and autoantibody generation and clear-up [interleukin 1 receptor antagonist (IL1RN), interleukin 1-beta (IL1-β), tumor necrosis factor-alpha (TNF-α), lymphotoxin-alpha (LTA), tumor necrosis factor ligand superfamily, member 6 (TNFSF6), programmed cell death 1 (PDCD1), C2, and complement component 4 (C4)] were selected for study. Frequency of each candidate's genotype and allele between case and control were compared. Results were stratified by reanalyzing genotype data with relevant symptoms. Finally, improved computational data mining was used to analyze the phenotypes in a large data set. In the frequency analysis, only IL1-β was significantly associated with SLE. Stratification analysis showed a significant association with SLE symptoms between SLC5A11 and the other immune-related genes, with the exceptions of TNFSF6 and C4. SLC5A11 was significantly associated with low C4 (as was TNF-α), anti-Smith antibody (anti-Sm) (as was C2), serositis, and alopecia. Finally, SLC5A11 interacted with PDCD1, TNF-α, LTA, and C4. After our study, we concluded that SLC5A11 is involved with some immune effects and interacts with immune-related gene(s), consistent with its function as an autoimmune modifier gene. Furthermore, SLC5A11 might induce apoptosis through the TNF-α, PDCD1 pathway. The present genotype-phenotype mapping approach should be applicable to genetic study of other complex diseases.",
keywords = "Autoimmune modifier gene, Candidate gene association approach, Data mining, Sodium-dependent glucose cotransporter, Systemic lupus erythematosus",
author = "Tsai, {L. J.} and Hsiao, {S. H.} and Tsai, {L. M.} and Lin, {C. Y.} and Tsai, {J. J.} and Liou, {D. M.} and Lan, {J. L.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1111/j.1399-0039.2007.00975.x",
language = "English",
volume = "71",
pages = "114--126",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE

AU - Tsai, L. J.

AU - Hsiao, S. H.

AU - Tsai, L. M.

AU - Lin, C. Y.

AU - Tsai, J. J.

AU - Liou, D. M.

AU - Lan, J. L.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Genetic studies in several human autoimmune diseases suggest that the pericentromeric region of chromosome 16 might harbor an autoimmune modifier gene. We hypothesized that the sodium-dependent glucose cotransporter gene SLC5A11 is such a gene, and so might interact with immune-related genes. Herein, this hypothesis was tested in a genetic evaluation of the multiple gene effect in systemic lupus erythematosus (SLE). We used the case-control candidate gene association approach. Eight immune-related genes involved in inflammation and autoantibody generation and clear-up [interleukin 1 receptor antagonist (IL1RN), interleukin 1-beta (IL1-β), tumor necrosis factor-alpha (TNF-α), lymphotoxin-alpha (LTA), tumor necrosis factor ligand superfamily, member 6 (TNFSF6), programmed cell death 1 (PDCD1), C2, and complement component 4 (C4)] were selected for study. Frequency of each candidate's genotype and allele between case and control were compared. Results were stratified by reanalyzing genotype data with relevant symptoms. Finally, improved computational data mining was used to analyze the phenotypes in a large data set. In the frequency analysis, only IL1-β was significantly associated with SLE. Stratification analysis showed a significant association with SLE symptoms between SLC5A11 and the other immune-related genes, with the exceptions of TNFSF6 and C4. SLC5A11 was significantly associated with low C4 (as was TNF-α), anti-Smith antibody (anti-Sm) (as was C2), serositis, and alopecia. Finally, SLC5A11 interacted with PDCD1, TNF-α, LTA, and C4. After our study, we concluded that SLC5A11 is involved with some immune effects and interacts with immune-related gene(s), consistent with its function as an autoimmune modifier gene. Furthermore, SLC5A11 might induce apoptosis through the TNF-α, PDCD1 pathway. The present genotype-phenotype mapping approach should be applicable to genetic study of other complex diseases.

AB - Genetic studies in several human autoimmune diseases suggest that the pericentromeric region of chromosome 16 might harbor an autoimmune modifier gene. We hypothesized that the sodium-dependent glucose cotransporter gene SLC5A11 is such a gene, and so might interact with immune-related genes. Herein, this hypothesis was tested in a genetic evaluation of the multiple gene effect in systemic lupus erythematosus (SLE). We used the case-control candidate gene association approach. Eight immune-related genes involved in inflammation and autoantibody generation and clear-up [interleukin 1 receptor antagonist (IL1RN), interleukin 1-beta (IL1-β), tumor necrosis factor-alpha (TNF-α), lymphotoxin-alpha (LTA), tumor necrosis factor ligand superfamily, member 6 (TNFSF6), programmed cell death 1 (PDCD1), C2, and complement component 4 (C4)] were selected for study. Frequency of each candidate's genotype and allele between case and control were compared. Results were stratified by reanalyzing genotype data with relevant symptoms. Finally, improved computational data mining was used to analyze the phenotypes in a large data set. In the frequency analysis, only IL1-β was significantly associated with SLE. Stratification analysis showed a significant association with SLE symptoms between SLC5A11 and the other immune-related genes, with the exceptions of TNFSF6 and C4. SLC5A11 was significantly associated with low C4 (as was TNF-α), anti-Smith antibody (anti-Sm) (as was C2), serositis, and alopecia. Finally, SLC5A11 interacted with PDCD1, TNF-α, LTA, and C4. After our study, we concluded that SLC5A11 is involved with some immune effects and interacts with immune-related gene(s), consistent with its function as an autoimmune modifier gene. Furthermore, SLC5A11 might induce apoptosis through the TNF-α, PDCD1 pathway. The present genotype-phenotype mapping approach should be applicable to genetic study of other complex diseases.

KW - Autoimmune modifier gene

KW - Candidate gene association approach

KW - Data mining

KW - Sodium-dependent glucose cotransporter

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=38049168735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049168735&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0039.2007.00975.x

DO - 10.1111/j.1399-0039.2007.00975.x

M3 - Article

C2 - 18069935

AN - SCOPUS:38049168735

VL - 71

SP - 114

EP - 126

JO - HLA

JF - HLA

SN - 2059-2302

IS - 2

ER -